Click here to close now.

SYS-CON MEDIA Authors: XebiaLabs Blog, Sematext Blog, Trevor Parsons, Aria Blog, Pat Romanski

News Feed Item

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview

NEW YORK, Feb. 24, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview
http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acid...

`Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA's or other relevant authorities' approvals.

In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as "vegetarian," "kosher" or even "organic."

The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions. Omega-3 Polyunsaturated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits.

The report reviews, analyses and projects the market of marine and algal omega-3 polyunsaturated fatty acid ingredients for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries across North AmericaThe United States and Canada; EuropeGermany, France, Italy, Spain, Norway, Denmark, The United Kingdom and Rest of Europe; Asia-PacificChina, Japan, South Korea, India and Rest of Asia-Pacific.

Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients market analyzed in this study include EPA and DHA omega-3s from marine oils such as fish oils, krill oils and squid oils; and algal oils. The end use application markets covered in the report include dietary supplements, food & beverages, pet nutrition, infant nutrition, pharmaceuticals and clinical nutrition. Worldwide, consumption of Omega-3 polyunsaturated fatty acids (PUFAs), estimated at 123.8 thousand metric tons worth US$2.3 billion in 2013, is forecast to be 134.7 thousand metric tons valued at US$2.5 billion in 2014. By 2020, it is projected that demand for Omega-3 PUFAs globally would reach 241 thousand metric tons with a value of US$4.96 billion, thereby posting a volume CAGR of almost 10% and a value CAGR of 11.6% between 2013 and 2020.

This 410 page global market report includes 126 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global omega-3 ingredients market volume in metric tons and value in US$ by geographic region, the product segment and application area. This study profiles 42 key global players and 106 major players across North America – 29; Europe – 35; Asia-Pacific – 30 and Rest of World – 12. The report also provides the listing of the companies engaged in the manufacturing and supply of omega-3 PUFAs as well as major players in the omega-3 end-use industries such as human nutrition, pet nutrition and pharmaceuticals and major ingredient distributors across the globe. The global list of companies covers addresses, contact numbers and the website addresses of 294 companies.
PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 What is Omega-3?
1.1.1.1 Fatty Acids
1.1.1.1.1 Saturated Fatty Acids
1.1.1.1.2 Unsaturated Fatty Acids
1.1.1.1.3 Polyunsaturated Fatty Acids (PUFAs)
1.1.1.2 Omega-3 Fatty Acids
1.1.1.2.1 Categories of Omega-3 Fatty Acids
1.1.1.2.1.1 Short Chain Omega-3 Fatty Acids
1.1.1.2.1.1.1 Alpha-Linolenic Acid (ALA)
1.1.1.2.1.2 Long Chain Omega-3 Fatty Acids (LC-PUFAs)
1.1.1.2.1.2.1 Docosahexaenoic Acid (DHA)
1.1.1.2.1.2.2 Eicosapentaenoic Acid (EPA)
1.1.2 Dietary Sources of Omega-3 Fatty Acids
1.1.3 Omega-3 and Its Health Benefits
1.2 Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
1.2.1 Marine Oils
1.2.1.1 Fish Oil
1.2.1.2 Krill Oil
1.2.1.3 Other Marine Sources
1.2.2 Algae
1.2.3 Plants
1.3 Evolution of Omega-3 Fatty Acid Ingredient Forms
1.3.1 First Generation Omega-3 Forms
1.3.2 Second Generation Omega-3 Forms
1.3.3 Third Generation Omega-3 Forms
1.4 Omega-3 PUFA Ingredient Type Analysis
1.4.1 18/12 (30% omega-3) Fish Oils
1.4.2 Cod Liver Oils
1.4.3 Tuna Oils
1.4.4 Salmon Oils
1.4.5 Omega-3 Low Concentrate (40% to 55%) PUFAs
1.4.6 Omega-3 Medium Concentrate (60% to 80%) PUFAs
1.4.7 Omega-3 High Concentrate (above 85%) PUFAs
1.4.8 Krill Oils
1.4.9 Algal Oils
1.4.10 Other Omega-3 PUFAs
1.5 Omega-3 PUFA End-Use Application Analysis
1.5.1 Dietary Supplements
1.5.2 Pet Nutrition
1.5.3 Food & Beverages
1.5.4 Infant Nutrition
1.5.5 Pharmaceuticals
1.5.6 Clinical Nutrition
1.6 Manufacturing Processes for Omega-3 Fatty Acids
1.6.1 Chemistry of Omega-3 Fatty Acids
1.6.2 Processing of Fish Oils
1.6.3 Decontamination
1.6.4 Concentration Process
1.6.5 Production Technologies Used for Omega-3 Fatty Acid Concentrates
1.6.5.1 Chromatographic Methods
1.6.5.2 Distillation Method
1.6.5.3 Molecular Distillation (MD)
1.6.5.4 Low-Temperature Crystallization
1.6.5.5 Urea Complexation/Precipitation
1.6.5.6 Enzymatic Methods
1.6.5.6.1 Lipase-Catalyzed Hydrolysis
1.6.5.6.2 Lipase-Catalyzed Esterification
1.6.5.7 Supercritical Fluid Technology (SFT)
1.6.5.7.1 Supercritical Fluid Extraction (SFE)
1.6.5.7.2 Supercritical Fluid Chromatography (SFC)

2. GLOBAL REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS
2.1 Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
2.2 Health Claim Approvals
2.2.1 FDA Approved Health Claim
2.2.2 New European Health Claim Regulation Becomes Effective
2.2.2.1 EU Approves Omega-3 Heart Health Claims
2.2.3 Approved Health Claims in Other Regions
2.2.3.1 Canada
2.2.3.2 Australia and New Zealand
2.2.3.3 Japan
2.3 Pharmaceutical Omega-3 Drugs Approvals
2.4 Regulations and Standards for Fish oils

3. KEY MARKET TRENDS
3.1 Consumer Demand and Pharma Pipeline to Bolster Market for Highly Concentrated Omega-3 Ingredients
3.2 Microalgae Strains Current Bestsellers as New Sources of Long Chain Omega-3 PUFAs
3.2.1 Microalgae Production
3.2.2 Microalgae as Sources of n-3 LC-PUFA
3.2.3 Algae Oil Extraction
3.3 Ethyl Ester Forms of Omega-3 Being Overtaken in Popularity by Triglyceride Forms
3.4 Study Linking Prostrate Cancer with Omega-3 Intake Leaves US Market Dismal

4. INDUSTRY STRUCTURE AND COMPETETIVE LANDSCAPE
4.1 Global Omega-3 PUFAs Industry Supply Chain Overview
4.2 Global Omega-3 PUFAs Competitive Landscape
4.3 Global Omega-3 PUFAs Installed Capacities
4.3.1 Fish Oil Sourced Omega-3 PUFAs
4.3.2 Algal Oil Sourced Omega-3 PUFAs
4.3.3 Krill Oil Sourced Omega-3 PUFAs
4.4 Omega-3 PUFA Ingredient Prices, Applications and Value Proposition

5. KEY GLOBAL PLAYERS
Aker Biomarine AS
Algae Biosciences Corporation
Aurora Algae, Inc.
Austral Group S.A.A.
Ayanda AS
BASF SE
Pronova BioPharma ASA
BASF Pharma (Callanish) Limited
BASF AS
Berg Lipidtech As (BLT)
BTSA Biotecnologías Aplicadas S.L
Cellana Inc.
Chemport, Inc.
Croda International Plc
Denomega Pure Health
Enzymotec Ltd.
EPAX AS
Felda IFFCO LLC
GC Rieber Oils
Golden Omega SA
Guangdong Runke Bioengineering Co Ltd
Huatai Biopharm Inc.
Hubei Fuxing Biotechnology Co Ltd
Jiangsu Auqi Marine Biotechnology Co., Ltd.
KD-Pharma GmbH
Lonza Group Ltd
LYSI hf.
Marine Ingredients
Maruha Nichiro Foods Inc.
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Nippon Suisan Kaisha, Ltd. (Nissui)
Olvea Fish Oils (Olvea Group)
Omega Protein Corp.
InCon Processing LLC
Cyvex Nutrition, Inc.
Pharma Marine AS
Polaris Nutritional Lipids
Qualitas Health Inc
Royal DSM NV
Seven Seas Ltd
Sinomega Biotech Engineering Co Ltd
Smit Functional Oils (Smit & Zoon Group)
Solutex GC, S.L.
Source-Omega LLC
Stepan Company
TASA Omega SA (Tecnológica De Alimentos SA)
Zhejiang Shenzhou Marine Bio-Tech Co Ltd

6. KEY BUSINESS TRENDS
Enzymotec Ltd. Broadened its Migdal Ha'Emeq Production Unit
Qponics Invests $5.5 million to Produce Algae-based Omega-3 oils
Enzymotec Ltd. Partners with Polar Omega A/S to Commercialize Omega PC™
Nutegrity™, New Business Name of Omega Protein's Human Nutrition Division
Neptune and Rimfrost Enter into Supply Agreement
Scoular and Arctic Nutrition Combine Forces to Offer Romega™
GC Rieber Oils Selects Novel Ingredient Services as Exclusive Distributor
Omega Protein Corp Expands Production Capacity of Specialty Dairy Proteins
Acasti Enters into Manufacturing Alliance
FMC Corporation Takes Over Epax AS
Biosearch Life's Plants Get Halal Certification
Solutions4CO2 Inc and Quinlan Brothers Ltd Form a Joint Venture
Bioseutica Divests Omega-3 Business to German Equity Firm Capiton
SeaDragon on a Capacity Expansion Spree
Qualitas Health and Valicor Renewables Enter into an Alliance
Golden Omega Recognized as a "Responsible" Supplier Of Omega-3 Fish Oils by IFFO
BASF Acquires Pronova BioPharma ASA
Tasa to Commence Concentrated Omega Oil Production in Peru
Algae Production Facility Acquired by Solarvest BioEnergy Inc
Amarin Includes Slanmhor Pharmaceutical Inc into its Global Supply Chain
Qponics and Nutrition Care Pharmaceuticals Sign a Memorandum of Understanding (MoU)
Aurora Algae Obtains US$2.01 Million Grant
Royal DSM Takes Over Ocean Nutrition Canada
Grain Millers, Inc Takes Over Milling Assets of ENRECO, Inc
Equateq Ltd Acquired by BASF
Stauber Performance Ingredients Takes Over Pharmline
Neptune Mass Markets NKO® Premium Krill Oil through Jamieson Laboratories
AlgiSys Successful in Raising US$2.5 Million
Phase-I Facility Expansion Initiated by Neptune at Sherbrooke
Photonz Corp Transfers Fermentation Process to a Canadian Contract Facility
Pfizer Acquires Ferrosan's Consumer Health Operations
Golden Omega's Omega-3 Concentrate Plant Granted Environmental Approval
Cargill and BASF Plant Science in Collaboration for Developing EPA/DHA Canola Oil
Lipid Technologies Retained as Strategic Consultant by Omega Protein
EID Parry Acquires Valensa
GC Rieber Oils Sets Up North American Office
Omega Protein Acquires InCon Processing LLC
Photonz and Novaesp Form an Alliance
Hofseth Biocare's First Processing Facility in Midsund, Norway Inaugurated
Hofseth Biocare Appoints TSI Health Sciences as Distributor
Neptune Reinforces Asian Operations by Entry into Indian Market
Stepan Takes Over Select Product Lines from Lipid Nutrition BV
Minami Nutrition Grants Distribution Rights to Garden of Life LLC
Worldwide Supply Network for AMR101 Formed by Amarin
Photonz Corp and Separax SAS Sign an Agreement
Enzymotec and Lupin Sign a Contract
Ocean Nutrition Canada and Wilmar International Enter into Strategic Agreement
Royal DSM Acquires Martek Biosciences Corp
Omega Protein Acquires Cyvex Nutrition
Minami Nutrition Acquired by Atrium Innovations
Omega-3 Concentration Facility Inaugurated by GC Rieber Oils
Polaris Acquires Ocean Nutrasciences
Aurora Algae's Operations Extended to Perth, Australia
Pizzey's Nutritionals Rebranded as Glanbia Nutritionals
Oxford Nutrascience and Ocean Nutrition Canada Sign an Agreement
China Grants Approval for Food Use of Omega-3
Aker BioMarine and Lindsay Goldberg in an Equal Joint Venture
Twin Rivers Technologies Acquired by Felda IFFCO Sdn Bhd, Renamed FINA LLC

7. KEY PRODUCT/TECHNOLOGY TRENDS
Novel 100% Canadian Omega-3 Rich Camelina Sativa Oil from Biodroga Inc
Enzymotec's K-REAL® Krill Oil Certified by "New Food Raw Material"
LYSI Starts the Supply of FoS-Certified Omega-3 Oil
Neptune Certified by "New Food Raw Material" in China
Investigational New Drug Submission of Acasti Receives FDA Approval for its PK trial of CaPre®
"New Food Raw Material" Certification for Aker BioMarine's Superba™ Krill
Application Submitted by Rothamsted Research to DEFRA for Producing Omega-3 from GM Camelina Sativa
Croda Received IFOS™ 5-Star Supplier Certification for its Incromega™
Omega3 Innovations' Omega Heaven Receives 2013 Supply Side Editors Choice Award
DSM Unveils Algal Omega-3 Oil
First Swedish Algal Omega-3 Oil Launched by Simris
Ecoduna Develops and Tests Bioreactor Prototype for Industrial Production of Microalgae
Source-Omega Launches POWER OMEGA™ Omega-3 Mini Softgel
PURE ONE® DHAlicious™ Omega-3 Chromista Oil Product Introduced by Source-Omega
GC Rieber Oils Launches VivoMega Line of Products in Asia
Omega-3 Products Launched by Nordic Naturals in Quebec
Qualitas Health Targets Commercial Quantities of Omega-3 Fatty Acids at Imperial, Texas Facility
Solarvest Bioenergy Inc Files Application for US Patent
Researchers Extract Omegas 3, 6 and 9 from Microalgae
BASF Unveils Newtrition™ Human Nutrition Brand
Omegatri Develops World's First Compressible Omega-3 Tablets to be Launched by Lysi HF
Taisho Pharmaceutical Introduces Epadel T
Amundsen Omega-3 Obtains Friend of the Sea Seal of Approval
Valensa International Launches Perilla Seed-Based Omega-3 Fatty Acid
AquaKrill Oil ™ Liquid Krill Oil Introduced by Azantis
Ayanda Revolutionizes Intake of Fish Oil by Humans
Oceans Omega's Omega Infusion™ Water Enhanced with Omega-3 Now in Giant Food Stores
Arctic Nutrition Innovates Omega-3 Extraction
EID Parry Targeting OTC Segment in India
Amarin Corp's Fish Oil Capsules Granted FDA Approval for Hypertriglyceridemia Patients
Cellana Introduces New Range of Algal Omega-3 Products
Omega-3 Product Targeting Women Introduced by Polaris Lipid Nutrition
OmeGo™ Salmon Oil Launched by Hofseth Biocare in the United States
Liver Lipid Metabolism Found to Improve by Krill Powder in Inflammation Prototype
Veda-Vida Innovations Introduces Omega-3 in High-Dose Powder Forms
Golden Omega Introduces New Range of Omega-3 Products
Pronova Marks Entry into the Omega-3 Supplements Sector
Golden Omega Showcases Products for the United States Market
Pharma Marine Introduces Oceans Omega-3 Ingredient Family
Enzymotec Debuts K*REAL Real Krill Oil
Hofseth Biocare to Commence Supply of Omega-3 with "24 Hour Virgin Oil" Salmon
Ascenta Launches NutraSea DHA
Organic Fat-Free Milk plus DHA Omega-3 Introduced by Horizon®
Neptune's NKO® Gets Approval from Health Canada
New Clinical Study Published by Aker BioMarine Pertaining to Superba™ Krill Oil
Results from DuPont Study on Omega-3 from GM Yeast Out
Eau Plus' Omega-3 from Algae Cynosure of Several Manufacturers
SourceOne and FINA Unveil Proprietary Technology for Omega-3 Emulsions
Cargill Launches Clear Valley® Omega-3 Oil
NutraVege Vegetarian Omega-3 Vegetarian Supplement Unveiled by Ascenta
Pharma Marine Group Launches Calamarine™ Sustainable Marine-Source DHA
Cenestra Health Obtains Omega-3 Formulations Patent

8. GLOBAL MARKET OVERVIEW
8.1 Global Omega-3 PUFAs Market Overview by End-Use Application
8.2 Global Omega-3 PUFAs Market Overview by Major Raw Material Source
8.3 Global Omega-3 PUFAs Market Overview by Ingredient Type

PART B: REGIONAL MARKET PERSPECTIVE
1. Global Omega-3 PUFAs Market Overview by Geographic Region
2. Global Marine Omega-3 PUFAs Market Overview by Geographic Region
3. Global Algal Omega-3 PUFAs Market Overview by Geographic Region
4. Global Omega-3 PUFAs End-Use Application Market Overview by Geographic Region
4.1 Dietary Supplements
4.2 Pet Nutrition
4.3 Food & Beverages
4.4 Infant Nutrition
4.5 Pharmaceuticals
4.6 Clinical Nutrition

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA
1.1 North American Omega-3 PUFAs Market Analysis by Major Raw Material Source
1.2 North America Omega-3 PUFAs Market Overview by Region
1.3 North America Omega-3 PUFAs Market Overview by End-Use Application
1.4 Major Market Players
Algae Biosciences Corporation (United States)
Algaentis, Inc (United States)
ALGisys LLC (United States)
Aurora Algae, Inc. (United States)
Biodroga Inc. (Canada)
Bioprocess Algae, LLC (United States)
Bioriginal Food & Science Corporation (Canada)
Cellana Inc. (United States)
Connoils LLC (United States)
Felda IFFCO LLC (United States)
Heliae Development LLC (United States)
Marine Ingredients (United States)
Neptune Technologies & Bioressources Inc. (Canada)
Nordic Naturals, Inc. (United States)
Novotech Nutraceuticals, Inc. (United States)
Nutrifynn Caps, Inc. (United States)
Oceans Omega, LLC (United States)
Omega Protein Corp. (United States)
Incon Processing LLC (United States)
Cyvex Nutrition, Inc. (United States)
Organic Technologies (United States)
Originates Inc (United States)
Pharmachem Laboratories, Inc. (United States)
Qualitas Health Inc (United States)
Rimfrost USA, LLC (United States)
Solarvest Bioenergy Inc. (Canada)
Source-Omega LLC (United States)
The Wright Group (United States)
Virun, Inc. (United States)
Wiley's Finest Inc (United States)
Zymes LLC (United States)

2. EUROPE
2.1 European Omega-3 PUFAs Market Analysis by Major Raw Material Source
2.2 European Omega-3 PUFAs Market Overview by Region
2.3 European Omega-3 PUFAs Market Overview by End-Use Application
2.4 Major Market Players
Aker Biomarine AS (Norway)
Arctic Nutrition AS (Norway)
Ayanda AS (Norway)
BASF SE (Germany)
Pronova BioPharma ASA (Norway)
BASF Pharma (Callanish) Limited (United Kingdom)
BASF AS (Norway)
Berg Lipidtech AS (BLT) (Norway)
Biosearch, S.A. (Biosearch Life) (Spain)
Bluebiotech International GmbH (Germany)
BTSA Biotecnologías Aplicadas S.L (Spain)
Copalis (France)
Croda International PLC (United Kingdom)
Denomega Pure Health (Norway)
Epax AS (Norway)
Flavex Naturextrakte GmbH (Germany)
GC Rieber Oils (Norway)
Hofseth Biocare AS (Norway)
IOI Imperial-Oel-Import (Germany)
KD-Pharma GmbH (Germany)
Lonza Group Ltd (Switzerland)
LYSI hf. (Iceland)
Marine Harvest Ingredients (Norway)
Norwegian Fish Oil (Norway)
Olvea Fish Oils (Olvea Group) (France)
Olympic Seafood AS (Norway)
Omegatri AS (Norway)
Omnipharm SAS (France)
Pharma Marine AS (Norway)
Polaris Nutritional Lipids (France)
Royal DSM NV (The Netherlands)
Seven Seas Ltd (United Kingdom)
Simris Alg AB (Sweden)
SMIT Functional Oils (SMIT & Zoon Group) (The Netherlands)
Solutex GC, S.L. (Spain)
Stepan Lipid Nutrition (The Netherlands)
Triplenine Group A/S (Denmark)
Vesteraalens AS (Norway)

3. ASIA-PACIFIC
3.1 Asia-Pacific Omega-3 PUFAs Market Analysis by Raw Material Source
3.2 Asia-Pacific Omega-3 PUFAs Market Overview by Region
3.3 Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
3.4 Major Market Players
AK & MN Biofarm Co Ltd (South Korea)
Arjuna Natural Extracts Limited (India)
Avesthagen Limited (India)
Bizen Chemical Co Ltd (Japan)
Chemport, Inc. (Korea)
Coastal Aquatic Proteins (India)
ECA Healthcare Inc (China)
Ennature Biopharma (India)
Fenchem Biotek Ltd (China)
Fujian Coland Enterprises Co Ltd (China)
Guangdong Runke Bioengineering Co Ltd (China)
Hebei Haiyuan Health Biological Science and Technology Co., Ltd. (China)
Huatai Biopharm Inc. (China)
Hubei Fuxing Biotechnology Co Ltd (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
Kinomega Biopharm Inc. (China)
Maruha Nichiro Foods Inc. (Japan)
Nippon Suisan Kaisha, Ltd. (Nissui) (Japan)
Nisshin Pharma Inc. (Japan)
Novosana (Taicang) Co. Ltd. (China)
Nu-Mega Ingredients Pty Ltd (Australia)
Parry Nutraceuticals (India)
Photonz Corporation (New Zealand)
Qponics Limited (Australia)
Seadragon Marine Oils Ltd (New Zealand)
Shandong Keruier Biological Products Co (China)
Shandong Yuwang Industry Co Ltd (China)
Sinomega Biotech Engineering Co Ltd (China)
Wuxi Xunda Marine Biological Products Co., Ltd. (China)
Zhejiang Shenzhou Marine Bio-Tech Co Ltd (China)

4. REST OF WORLD
4.1 Rest of World Omega-3 PUFAs Market Analysis by Major Raw Material Source
4.2 Rest of World Omega-3 PUFAs Market Analysis by End-Use Application
4.3 Major Market Players
Enzymotec Ltd. (Israel)
Austral Group S.A.A. (Peru)
Cox & Compañía S.A. (Chile)
Golden Omega SA (Chile)
Natural Oils Chile SA (Chile)
Naturmega SA (Colombia)
Pesquera Camanchaca SA (Chile)
Pesquera Diamante SA (Peru)
Pesquera Hayduk SA (Peru)
Quimica Industrial Spes SA (Spes SA) (Chile)
TASA Omega SA (Tecnológica De Alimentos SA) (Peru)
Vicami SA (Argentina)

PART C: OMEGA-3 PATENT LANDSCAPE
1. Fish Oil Omega-3 Fatty Acids
2. Algal Oil Omega-3 Fatty Acids

PART D: GUIDE TO THE INDUSTRY
1. Manufacturers of Omega 3 Ingredients
2. Pharma Companies in Omega 3 Drugs Market
3. Raw Material Producers, Omega 3 End Users and Other Related Companies in Omega 3 Industry
4. Major Ingredient Distributors

PART E: ANNEXURE
1. RESEARCH METHODOLOGY
2. THE QUESTIONNAIRE
3. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Omega-3 PUFAs Market Overview (2013 & 2020) in Volume (Metric Tons) and Value (US$ Million)
Table 1: Types of polyunsaturated omega-3 fatty acids
Table 2: Dietary Sources of Omega-3 Fatty Acids
Table 3: Alpha-Linolenic Acid Content of Selected Foods and Oils
Table 4: Leading Plant Sources of Alpha-Linolenic Acid (ALA)
Table 5: EPA + DHA Content in Selected Fish and Seafood per 85 Gram Serving
Table 6: Omega-3 Fatty Acids EPA and DHA in Microalgae
Table 7: Forms of Omega-3 Fatty Acid Ingredients
Chart 2: Snapshot for Global Omega3 PUFAs Market Share (2012) by Ingredient Type
Chart 3: Global 18/12 Fish Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 4: Global Cod Liver Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 5: Global Tuna Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 6: Global Salmon Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 7: Global Omega-3 Low Concentrate (40% to 55%) PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 8: Global Omega-3 Medium Concentrate (60% to 80%) PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 9: Global Omega-3 High Concentrate (above 85%) PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 10: Global Krill Oil Omega-3 PUFAs Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 11: Global Algal Oil Omega-3 PUFAs Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 12: Global Other Omega-3 PUFAs (Squid/Calamari etc.) Market Analysis by Volume (Metric Tons) and Value (US$ Million)
Chart 13: Snapshot for Global Omega3 PUFAs Market Share (2012) by End-Use Applications
Chart 14: Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 15: Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 16: Global Omega-3 PUFAs End-use Application in Food & Beverages Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 17: Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 18: Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 19: Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Analysis (2013 & 2020) by Volume (Metric Tons) and Value (US$ Million)
Table 8: Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake Globally
Table 9: Quality Specifications and Regulations Related to Omega-3 Oils
Table 10: Commercially available microalgae omega-3 oils
Table 11: Microalgae strains characterized by EPA production
Table 12: Microalgae strains characterized by DHA production
Figure 1: Omega-3 Supply Chain
Chart 20: Global Omega-3 PUFAs Market Share (%) by Manufacturer in US$ Millions in 2012
Table 13: M&A Activity in the Omega-3 Industry
Chart 21: Global Omega-3 PUFAs Installed Capacities (2012 and 2015E) by Country in Metric Tons
Chart 22: Global Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Raw Material Source in Metric Tons
Chart 23: Global Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Raw Material Source and Manufacturer in Metric Tons
Chart 24: Global Fish Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Country in Metric Tons
Chart 25: Global Fish Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Manufacturer in Metric Tons
Chart 26: Global Algal Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Country in Metric Tons
Chart 27: Global Algal Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Manufacturer in Metric Tons
Chart 28: Global Krill Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Country in Metric Tons
Chart 29: Global Krill Oil Omega-3 PUFAs Installed Capacity (2012 and 2015E) by Manufacturer in Metric Tons
Table14: Price Levels of Different Omega-3 PUFAs
Figure 2: Omega-3 PUFA Ingredients and End-use Applications
Figure 3: Omega-3 PUFAs Value Proposition

GLOBAL MARKET OVERVIEW
Chart 30: Global Omega-3 PUFAs Market Analysis (2009-2020) in Volume (Metric Tons) and Value (USD Million)
Chart 31: Global Omega-3 PUFAs Market Overview (2009-2020) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 32: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Volume Share (%) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 33: Global Omega-3 PUFAs Market Overview (2009-2020) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 34: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Market Share (%) by End-use Application – Dietary Supplements, Pet Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 35: Global Omega-3 PUFAs Market Analysis (2009-2020) by Major Raw Material Sources – Marine Oils and Algal Oils in Metric Tons
Chart 36: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Volume Share (%) by Major Raw Material Sources – Marine Oils and Algal Oils
Chart 37: Global Omega-3 PUFAs Market Analysis (2009-2020) by Major Raw Material Sources – Marine Oils and Algal Oils in USD Million
Chart 38: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Market Share (%) by Major Raw Material Sources – Marine Oils and Algal Oils
Chart 39: Global Omega 3 PUFAs Market Overview (2009-2020) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils in Metric Tons
Chart 40: Glance at 2010, 2015 and 2020 Global Omega 3 PUFAs Volume Share (%) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils
Chart 41: Global Omega 3 PUFAs Market Overview (2009-2010) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils in USD Million
Chart 42: Glance at 2010, 2015 and 2020 Global Omega 3 PUFAs Market Share (%) by Product Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cord Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Oils, Algal Oils and Squid Oils

PART B: REGIONAL MARKET PERSPECTIVE
Chart 43: Global Omega-3 PUFAs Market Overview (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 44: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 45: Global Omega-3 PUFAs Market Overview (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 46: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 47: Global Marine Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 48: Glance at 2010, 2015 and 2020 Global Marine Oil Omega-3 PUFAs Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 49: Global Marine Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 50: Glance at 2010, 2015 and 2020 Global Marine Oil Omega-3 PUFAs Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 51: Global Algal Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 52: Glance at 2010, 2015 and 2020 Global Algal Oil Omega-3 PUFAs Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 53: Global Algal Oil Omega-3 PUFAs Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 54: Glance at 2010, 2015 and 2020 Global Algal Oil Omega-3 PUFAs Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 55: Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 56: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Dietary Supplements Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 57: Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 58: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Dietary Supplements Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 59: Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 60: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pet Nutrition Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 61: Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 62: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pet Nutrition Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 63: Global Omega-3 PUFAs End-use Application in Food & Beverages Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 64: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Food & Beverages Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 65: Global Omega-3 PUFAs End-use Application in Food & Beverages Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 66: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Food & Beverages Market Share (%) by Geographic Region –North America, Europe, Asia-Pacific and Rest of World
Chart 67: Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Analysis (2009-2020) by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 68: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Infant Nutrition Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 69: Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 70: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Infant Nutrition Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 71: Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 72: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pharmaceuticals Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 73: Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 74: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Pharmaceuticals Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 75: Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in Metric Tons
Chart 66: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Clinical Nutrition Volume Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 77: Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Analysis (2009-2020) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 78: Glance at 2010, 2015 and 2020 Global Omega-3 PUFAs End-use Application in Clinical Nutrition Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 79: North American Omega-3 PUFAs Market Overview (2009-2020) by Volume (Metric Tons) and Value (US$ Million)
Chart 80: North American Omega-3 PUFAs Market Analysis (2009-2020) by Major Raw Material Source – Marine Oils and Algal Oils in Metric Tons
Chart 81: Glance at 2010, 2015 and 2020 North American Omega-3 PUFAs Volume Share (%) by Majo


To order this report: Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview
http://www.reportlinker.com/p02029889/Omega-3-Polyunsaturated-Fatty-Acids-PUFAs---A-Global-Market-Overview.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The explosion of connected devices / sensors is creating an ever-expanding set of new and valuable data. In parallel the emerging capability of Big Data technologies to store, access, analyze, and react to this data is producing changes in business models under the umbrella of the Internet of Things (IoT). In particular within the Insurance industry, IoT appears positioned to enable deep changes by altering relationships between insurers, distributors, and the insured. In his session at @Things...
When it comes to the Internet of Things, hooking up will get you only so far. If you want customers to commit, you need to go beyond simply connecting products. You need to use the devices themselves to transform how you engage with every customer and how you manage the entire product lifecycle. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, will show how “product relationship management” can help you leverage your connected devices and the data th...
SYS-CON Media announced that IBM, which offers the world’s deepest portfolio of technologies and expertise that are transforming the future of work, has launched ad campaigns on SYS-CON’s numerous online magazines such as Cloud Computing Journal, Virtualization Journal, SOA World Magazine, and IoT Journal. IBM’s campaigns focus on vendors in the technology marketplace, the future of testing, Big Data and analytics, and mobile platforms.
PubNub on Monday has announced that it is partnering with IBM to bring its sophisticated real-time data streaming and messaging capabilities to Bluemix, IBM’s cloud development platform. “Today’s app and connected devices require an always-on connection, but building a secure, scalable solution from the ground up is time consuming, resource intensive, and error-prone,” said Todd Greene, CEO of PubNub. “PubNub enables web, mobile and IoT developers building apps on IBM Bluemix to quickly add sc...
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy architecture and infrastructure into account. Then the reality is that most enterprises are embarking on a hybrid cloud strategy and programs. In this Power Panel at 15th Cloud Expo (http://www.CloudComputingExpo.com...
There has been a lot of discussion recently in the DevOps space over whether there is a unique form of DevOps for large enterprises or is it just vendors looking to sell services and tools. In his session at DevOps Summit, Chris Riley, a technologist, discussed whether Enterprise DevOps is a unique species or not. What makes DevOps adoption in the enterprise unique or what doesn’t? Unique or not, what does this mean for adopting DevOps in enterprise size organizations? He also explored differe...
“In the past year we've seen a lot of stabilization of WebRTC. You can now use it in production with a far greater degree of certainty. A lot of the real developments in the past year have been in things like the data channel, which will enable a whole new type of application," explained Peter Dunkley, Technical Director at Acision, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
NaviSite, Inc., a Time Warner Cable company, has opened a new enterprise-class data center located in Santa Clara, California. The new data center will enable NaviSite to meet growing demands for its enterprise-class Cloud and Managed Services from existing and new customers. This facility, which is owned by data center solution provider Digital Realty, will join NaviSite’s fabric of nine existing data centers across the U.S. and U.K., all of which are designed to provide a resilient, secure, hi...
SYS-CON Events announced today that Intelligent Systems Services will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Established in 1994, Intelligent Systems Services Inc. is located near Washington, DC, with representatives and partners nationwide. ISS’s well-established track record is based on the continuous pursuit of excellence in designing, implementing and supporting nationwide clients’ mission-cri...
Data-intensive companies that strive to gain insights from data using Big Data analytics tools can gain tremendous competitive advantage by deploying data-centric storage. Organizations generate large volumes of data, the vast majority of which is unstructured. As the volume and velocity of this unstructured data increases, the costs, risks and usability challenges associated with managing the unstructured data (regardless of file type, size or device) increases simultaneously, including end-to-...
The cloud has transformed how we think about software quality. Instead of preventing failures, we must focus on automatic recovery from failure. In other words, resilience trumps traditional quality measures. Continuous delivery models further squeeze traditional notions of quality. Remember the venerable project management Iron Triangle? Among time, scope, and cost, you can only fix two or quality will suffer. Only in today's DevOps world, continuous testing, integration, and deployment upend...
The truth is, today’s databases are anything but agile – they are effectively static repositories that are cumbersome to work with, difficult to change, and cannot keep pace with application demands. Performance suffers as a result, and it takes far longer than it should to deliver new features and capabilities needed to make your organization competitive. As your application and business needs change, data repositories and structures get outmoded rapidly, resulting in increased work for applica...
The excitement around the possibilities enabled by Big Data is being tempered by the daunting task of feeding the analytics engines with high quality data on a continuous basis. As the once distinct fields of data integration and data management increasingly converge, cloud-based data solutions providers have emerged that can buffer your organization from the complexities of this continuous data cleansing and management so that you’re free to focus on the end goal: actionable insight.
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
Between the compelling mockups and specs produced by your analysts and designers, and the resulting application built by your developers, there is a gulf where projects fail, costs spiral out of control, and applications fall short of requirements. In his session at DevOps Summit, Charles Kendrick, CTO and Chief Architect at Isomorphic Software, will present a new approach where business and development users collaborate – each using tools appropriate to their goals and expertise – to build mo...